Prolonged Administration Enhances the Renoprotective Effect of Pentoxifylline via Anti-Inflammatory Activity in Streptozotocin-Induced Diabetic Nephropathy

Citations

WEB OF SCIENCE

17
Citations

SCOPUS

16

초록

The beneficial effects of pentoxifylline (PTX), which has an anti-inflammatory and renoprotective effect in diabetic nephropathy, are not completely understood. This study investigates whether prolonged administration of PTX (40 mg/kg, per oral) is effective in streptozotocin-induced diabetic nephropathy. The amount of urinary protein was higher in the diabetic rats than in the control rats. The amount remained unchanged after 4 weeks and decreased after 8 weeks of PTX treatment. Accumulation of monocyte chemoattractant peptide-1 (MCP-1) and mouse monoclonal anti-monocyte/macrophage antibody (ED-1) positive cells was higher in untreated diabetic rats than in the control rats. PTX administration ameliorated the urinary MCP-1 excretion and interstitial infiltration of ED-1 positive cells at 4 weeks. Further, in diabetic rats, administration of PTX for 4 weeks inhibited the renal inflammatory reaction, and when administration for 8 weeks, it prevented proteinuria. These findings support the hypothesis that prolonged administration enhances the protective effects of PTX.

키워드

diabetic nephropathyinflammationpentoxifyllineMONOCYTE CHEMOATTRACTANT PROTEIN-1CONVERTING ENZYME-INHIBITIONTUMOR-NECROSIS-FACTORURINARY PROTEINGENE-THERAPYRENAL INJURYSHORT-TERMRATSPROGRESSIONCOMPLICATIONS
제목
Prolonged Administration Enhances the Renoprotective Effect of Pentoxifylline via Anti-Inflammatory Activity in Streptozotocin-Induced Diabetic Nephropathy
저자
Han, Kum HyunHan, Sang YoubKim, Han SeongKang, Young SunCha, Dae Ryong
DOI
10.1007/s10753-009-9167-6
발행일
2010-06
유형
Article
저널명
Inflammation
33
3
페이지
137 ~ 143